Loss of fragile histidine triad protein expression in inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

323

HTML

2369

Figures (1-1)

153

Tables (1-2)

143

Sum=2988

Dec 7, 2006 (publication date) through Jul 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2006; 12(45): 7355-7360
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7355

Table 2 Comparison of FHIT protein immunohistochemical expression in ulcerative colitis, Crohn’s disease, and normal colon mucosa (mean ± SD)

Groups	n	Positive rate of FHITprotein expression (%)
Normal colon mucosa	10	57.05 ± 8.86
Ulcerative colitis
Active	33	22.79 ± 16.16
Remittent	14	42.14 ± 16.82
Crohn’s disease	17	36.07 ± 19.23

Citation: Xu CM, Qiao CH. Loss of fragile histidine triad protein expression in inflammatory bowel disease. World J Gastroenterol 2006; 12(45): 7355-7360
URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7355.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7355